Tandem Health Raises $100 Mn Series B to Expand AI Healthcare Platform Across Europe
Sep 14, 2026 | By Oliver Bennett

Healthcare AI company Tandem Health has raised $100 million in Series B funding. The round was led by the Scaleup Europe Fund, managed by EQT. Tandem Health is the first healthcare AI company backed by the fund which focuses on helping ambitious European technology companies grow into global businesses.
SUMMARY
- Tandem Health has raised $100 million in Series B funding led by the Scaleup Europe Fund, managed by EQT.
- Existing investors Kinnevik, Northzone, Amino Collective, and Visionaries also participated.
- The company develops AI tools for healthcare professionals, including clinical documentation, medical coding, and decision support.
Existing investors Kinnevik, Northzone, Amino Collective, and Visionaries also participated in the round. The new funding comes after Tandem Health raised $50 million in Series A funding in 2025 bringing the company’s total funding raised to $160 million.
Lukas Saari, CEO and co-founder of Tandem Health, said: "Europe’s health systems are under real strain and AI presents a tangible solution. But until now, European care providers have had to depend either on legacy solutions or AI solutions originally built for other markets that were retrofitted for Europe. We started Tandem to provide an alternative. Europe should be setting the standard for how AI enters healthcare, not adopting someone else’s. This funding lets us do that, bringing healthcare safely into the AI era, working in tandem with patients, clinicians, systems and nations. That’s how we’re taking care of healthcare."
Nils Petter Nygaard, Managing Director at EQT and Scaleup Europe Fund, said: "European healthcare is complex. Tandem is one of the few healthcare technology companies to demonstrate that it can scale pan-European, already supporting more than 10,000 care organisations with AI that reduces administrative burden and frees up time for higher-impact work. We believe Tandem has the potential to become a foundational AI layer for European healthcare over the coming decades."
RECOMMENDED FOR YOU
Yazen Health Funding News – Stockholm-based Yazen Health secures €19.5 million
Oliver Bennett
Nov 4, 2024
Top 10 Funding Wrap of the Week – September 2 – September 6 2024
Oliver Bennett
Sep 7, 2024
Tandem Health is a European healthtech company that develops trusted AI tools for healthcare professionals. Its AI Medical Assistant helps doctors and other clinicians throughout patient visits, including writing clinical notes, handling medical coding and supporting clinical decisions.
Tandem Health’s technology is CE marked under the EU Medical Device Regulation and has certifications including ISO 27001, ISO 13485, ISO 42001, and BSI C5. The platform is connected to more than 130 medical record systems across Europe and is used by 10,000 healthcare organisations across 14 markets.
Read Also- Nscale Appoints Former OpenAI Executive Fidji Simo to Its Board of Directors
Recommended Stories for You
Cambridge Future Tech funding news – Cambridge-based Cambridge Future Tech Secures $5Million in Funding
Oliver Bennett May 31, 2024
[Funding alert] Hamburg-based Bioeconomy Startup Traceless Raises €36.6 million in Series A Funding
Oliver Bennett Sep 25, 2023
Amsterdam’s Keen Venture Partners Secures €150M First Close For Europe-Focused Defence And Security Fund
Kailee Rainse Nov 18, 2025




